.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Novartis
Federal Trade Commission
AstraZeneca
Covington
McKinsey
Accenture
Chinese Patent Office
Baxter
Colorcon

Generated: December 13, 2017

DrugPatentWatch Database Preview

RENOVUE-65 Drug Profile

« Back to Dashboard

When do Renovue-65 patents expire, and what generic alternatives are available?

Renovue-65 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in RENOVUE-65 is iodamide meglumine. There is one drug master file entry for this compound. Additional details are available on the iodamide meglumine profile page.

Summary for RENOVUE-65

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 4
Patent Applications: 22
Drug Prices:see details
DailyMed Link:RENOVUE-65 at DailyMed
Drug patent expirations by year for RENOVUE-65

Medical Subject Heading (MeSH) Categories for RENOVUE-65

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
BraccoRENOVUE-65iodamide meglumineINJECTABLE;INJECTION017902-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Chinese Patent Office
Covington
Daiichi Sankyo
Queensland Health
US Army
Novartis
Farmers Insurance
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot